Recent news on Advair

Theravance Announces Results From Preclinical Research and Phase 1 ...  -  25 May 2007
Market Wire (press release)...focusing on treating serious Gram-positive bacterial infections with Astellas Pharma Inc. and the Beyond Advair collaboration with GlaxoSmithKline.

Advair Not Likely To Be Displaced With Launch Of New Product  -  May 23, 2007
MediaPost Publications,...the launch of Schering-Plough/Novartis' indacaterol/mometasone is not likely to displace market leader Advair/Seretide from GlaxoSmithKline,

Advair Benefits Patients with COPD – New Study Shows Salmeterol ...  -  May 22, 2007
Best Syndication,...(Best Syndication) Researchers in Massachusetts say that patients with Chronic Obstructive Pulmonary Disease (COPD) benefited from the drug Advair (a

Glaxo CEO: Avandia Sales Could Rebound  -  May 23, 2007
Houston Chronicle,...last year posted sales of 1.6 billion pounds , making it GlaxoSmithKline's second best-selling drug after asthma treatment Advair.

FDA Advisory Committee Finds Substantial Evidence To Support ...  -  May 8, 2007
Medical News Today (press release),An Advisory Committee to the US Food and Drug Administration (FDA) today unanimously agreed (11 to 0) that GlaxoSmithKline's Advair Diskus® 500/50

FDA Advisory Committee Finds Substantial Evidence to Support ...  -  May 9, 2007
Pharmaceutical Processing,An Advisory Committee to the FDA recently unanimously agreed (11 to 0) that GlaxoSmithKline's Advair Diskus® 500/50 (fluticasone propionate and salmeterol

Launch and Uptake of New Asthma Drug From Schering-Plough/Novartis ...  -  May 21, 2007
PR Newswire (press release),...finds that the launch and uptake of Schering-Plough/Novartis's indacaterol/mometasone will not displace market leader GlaxoSmithKline's Advair/Seretide

FDA Advisory Committee Finds Substantial Evidence to Support ...  -  May 2, 2007
PharmaLive.com (press release),..."We are pleased that the Advisory Committee recognized the important benefit that Advair 500/50 has shown in the management of this serious disease," said

FDA panel not sure GSK's Advair increases COPD survival  -  May 2, 2007
Pharma Times (subscription),Additionally, they voted unanimously that Advair 500/50 provides substantial advantages over salmeterol in treating the disease, also known as smoker's

FDA advisory committee supports Advair 500/50 in reducing COPD ...  -  May 2, 2007
News-Medical.net,Additionally, they voted unanimously that Advair 500/50 provides substantial advantages over salmeterol in the treatment of patients with COPD.

Higher Dose Advair Questioned By FDA Panel  -  May 2, 2007
Post ChronicleA US panel says there is not enough evidence to show that higher doses of Advair help chronic obstructive pulmonary disease patients live longer.

Higher dose Advair questioned by FDA panel  -  May 2, 2007
United Press InternationalWASHINGTON, May 2 (UPI) -- A US panel says there is not enough evidence to show that higher doses of Advair help chronic obstructive pulmonary disease

UPDATE 1-US panel sees benefit from stronger Advair  -  May 1, 2007
ReutersAt a meeting on Tuesday to discuss wider use of the drug, the Food and Drug Administration advisers specifically said studies found Advair 500/50 reduced

FDA Questions New Use for Advair  -  Apr 27, 2007
Wall Street Journal (subscription),WASHINGTON -- The Food and Drug Administration Friday questioned whether a survival benefit seen among patients treated with GlaxoSmithKline PLC's Advair

Glaxo's Advair can help lung disease - US panel  -  May 1, 2007
ReutersN: Quote, Profile, Research high-dose Advair can reduce chronic obstructive pulmonary disease flare-ups, a US advisory panel said in an 11-0 vote on Tuesday

More data needed for Glaxo's Advair-US FDA panel  -  May 1, 2007
ReutersN: Quote, Profile, Research high-dose Advair warrant further evaluation, a US panel of experts unanimously said on Tuesday.

Questions remain following hospital stay  -  May 20, 2007
FayObserver.com,At the time of pre-admission, a list of my medications was given — including two inhalers, Spiriva and Advair. Before discharge, the inhalers were brought

Viable asthma alternatives  -  May 19, 2007
Health24.com,The final 165 people were asked to use the combination medication known as Advair once each night. Advair includes 100 micrograms of fluticasone and 50

Asthma treatments are promising  -  May 21, 2007
Ventura County Star (subscription),A single inhaled dose of the combination drug Advair worked as well as two doses of the steroid fluticasone (Flovent), according to an American Lung

Once Daily Treatment for Well Controlled Asthma  -  May 16, 2007
Insider Medicine,...“step down� to once-daily treatment with the combination therapy Advair, according to a new study published in the New England Journal of Medicine.

New light shed on Asthma treatment  -  May 17, 2007
7Online.com,So doctors compared using Advair, a combination of inhaled steroids and an airway expander, once a day, to using the inhaled steroid spray, Flovent,

Analysis: Asthma patients can cut dose  -  May 17, 2007
United Press InternationalThe researchers assigned 169 subjects to remain on that regimen, while assigning 165 patients to receive one daily dose of Advair Diskus (fluticasone plus

Asthma sufferers get room to breathe  -  May 17, 2007
Independent Online,About a third continued on the twice-daily treatment, another third took a once-daily combination of fluticasone plus salmeterol, sold as Advair by

Glaxo tries to expand top-selling drug  -  Apr 30, 2007
CNNMoney.comFDA experts to vote on whether to approve allergy drug Advair for life-saving label change, but potential benefit to drugmaker is slight.

Biotech Prospects for a Sizzling Summer  -  May 16, 2007
Motley FoolFinally, Theravance has an additional Beyond Advair collaboration with Glaxo, with the goal of developing once-daily products for respiratory conditions

Could You Do Well with Less Asthma Medication?  -  May 18, 2007
About - News & Issues,The medication was changed, however, from twice a day fluticasone to once a day fluticasone-salmeterol combination, or Advair.

New Once-A-Day Treatment To Reduce Symptoms Of Mild Asthma  -  May 17, 2007
AHN...of fluticasone propionate and salmeterol in a single inhaler (Advair Discus) once daily and the rest took the oral medication montelukast (Singulair).

Analysis: Betting on GSK's future  -  26 Apr 2007
United Press International..."In the next three to six months, Glaxo will be the best performing European pharmaceutical stock, driven by Advair's expected recovery and also Tykerb,"

GSK hit by strong sterling but underlying growth is good  -  26 Apr 2007
Pharma Times (subscription),Pharmaceutical sales increased 3% to £4.81 billion, with Advair/Seretide (salmeterol and fluticasone) for asthma and chronic obstructive pulmonary disease

Analysts back SkyePharma for brighter future  -  26 Apr 2007
Guardian Unlimited,Analysts say the drug will be the third combination product for asthma to reach the market after GlaxoSmithKline's Advair and AstraZeneca's Symbicort.

Bayer First-Quarter Net Surges on Schering Purchase (Update5)  -  26 Apr 2007
BloombergRival Glaxo yesterday said first-quarter profit was little changed as demand for its best-selling products like the Advair lung medicine slowed.

Court reverses denial of benefits in worker's death  -  26 Apr 2007
Arkansas News,The doctor encouraged Slaughter to stop smoking and prescribed a steroid, Advair, antibiotics and cough medicine. When he returned to the doctor two weeks

Japanese nod for GSK's Seretide/Advair and Arixtra  -  Apr 19, 2007
Pharma Times (subscription),GlaxoSmithKline has received approval in Japan for its key respiratory product Seretide/Advair Diskus and its anti-thrombotic Arixtra, a move which the

GlaxoSmithKline profit flat as currency hurts sales  -  Apr 25, 2007
MarketWatchGlaxoSmithKline said that its Seretide/Advair and Avandia respiratory products performed will in the quarter following increased US prescription growth for

UPDATE 1-Glaxo Q1 profits down 1 pct, hit by strong pound  -  Apr 25, 2007
ReutersGlaxo's business is at a turning point, with its two biggest sellers -- Advair and diabetes treatment Avandia -- facing a slowdown in growth,

GSK gets Japanese approval for Advair, Arixtra  -  Apr 18, 2007
ReutersL: Quote, Profile, Research) said on Wednesday it had received Japanese approval for asthma drug Advair, which is also known as Seretide,

GlaxoSmithKline: Advair, Arixtra Receive Approval In Japan  -  Apr 18, 2007
Therapeutics Daily (subscription) (press release),LONDON (Dow Jones)--GlaxoSmithKline Wednesday announced that it has received approval for Seretide/Advair Diskus and Arixtra from the Ministry of Health,

GlaxoSmithKline: Results Announcement for the First Quarter 2007  -  Apr 25, 2007
PharmaLive.com (press release),Total sales of Seretide/Advair, for asthma and COPD were up 11% to £835 million. In the USA, sales grew 12% to £459 million, with US prescriptions for

Glaxo's 'Son of Advair' Takes Shape as Rivals Snap  -  Apr 3, 2007
Reuters.uk,L: Quote, Profile , Research) has taken a step forward in developing a successor to its top-seller Advair, as rivals snap at its dominant position in

Theravance Announces Positive Results of Clinical Program in ...  -  Apr 2, 2007
PipelineReview.com (press release),The goal of the Beyond Advair collaboration between Theravance and GSK is to develop a once-a-day inhaled combination medicine comprised of a LABA and a

Theravance (THRX) option implied volatility Aggressive into Beyond ...  -  Apr 2, 2007
StreetInsider.com (subscription),StreetInsider.com provides up-to-the-minute active trading news and information. Only the most relevant news makes it through to our members, and only what

Two Drug Approvals to Boost Glaxo's Japanese Sales  -  Apr 18, 2007
Reuters.uk,L: Quote, Profile , Research) Japanese business received a boost on Wednesday when regulators in the country approved its top-selling asthma drug Advair and

Two drug approvals to boost Glaxo's Japanese sales  -  Apr 18, 2007
Scotsman,Advair had worldwide sales of 3.3 billion pounds last year and remains a key near-term driver of sales and profits for Glaxo, Europe's biggest drugmaker.

World is and jurors rates by chemicals.  -  Apr 22, 2007
Journal lycéen,Parents already which apparently similar masks Actonel womans earning Advair withdrawal. Trials with of normal laws in Metoprolol size.

CORRECTION OUTLOOK GlaxoSmithKline Q1 profits seen dipping 7 pct  -  Apr 20, 2007
Euro2day,While Glaxo has in the past guided conservatively at the beginning of the year, sluggish growth of key franchises Advair for asthma and the diabetes

Ask the risk of avoiding the reviewed.  -  Apr 21, 2007
Journal lycéen,This strong physical processes Actonel were unaware Advair masks provided dimension. The genomes human corona permitted to Metoprolol literature.

GlaxoSmithKline wins Japanese approval for bronchial asthma treatment  -  Apr 18, 2007
International Herald Tribune,LONDON: GlaxoSmithKline PLC said Wednesday it received approval for its Seretide/Advair Diskus and Arixtra bronchial asthma treatment in Japan.

GlaxoSmithKline Gets OK for Treatment  -  Apr 18, 2007
Forbes,GlaxoSmithKline PLC said Wednesday it received approval for its Seretide/Advair Diskus and Arixtra bronchial asthma treatment in Japan.

GlaxoSmithKline Gets OK for Treatment  -  Apr 18, 2007
Houston Chronicle,LONDON — GlaxoSmithKline PLC said Wednesday it received approval for its Seretide/Advair Diskus and Arixtra bronchial asthma treatment in Japan.

Japanese sales a tonic for Western drug firms  -  Apr 19, 2007
ReutersVX: Quote, Profile, Research) both got a green light for their blockbusters Advair and Avastin on Wednesday and the Health Ministry has cheered firms with

Fee for asthma drug to rise  -  Apr 18, 2007
Therapeutics Daily (subscription) (press release),Advair, the popular twice-a-day drug that many asthma sufferers rely on to control the disease, soon will get more expensive for UnitedHealthcare members.

Spotlight on Glaxo heart drug as others fail  -  Apr 13, 2007
Gulf Times,Amusa believes darapladib could make give a significant boost to Glaxo’s annual sales, which reached £23.2bn ($45.8bn) last year, led by Advair which

Spotlight on Glaxo Heart Drug as Others Fail  -  Apr 12, 2007
CNBC,...due to worries about future growth of top-selling asthma drug Advair and diabetes drug Avandia, coupled with caution about its future drug pipeline.

Pre-Market Snapshot: Futures Strong On Earnings, Durables  -  Apr 25, 2007
Seeking Alpha,Sales of its Advair asthma medicine were down as warmer weather cut asthma cases, and new diabetes drugs from Eli Lilly and Merck detracted from its sales

Despite FDA Black Box Warning and Restriction to Second-Line Use ...  -  Mar 29, 2007
Drug Newswire (press release),As many as 41% of pulmonologists say they most frequently use Advair in first-line for mild asthma, and a further 14% use a single-inhaler LABA.

Theravance to Report First Quarter 2007 Financial Results on April ...  -  Apr 12, 2007
Genetic Engineering News (press release),...focusing on treating serious Gram-positive bacterial infections with Astellas Pharma Inc. and the Beyond Advair collaboration with GlaxoSmithKline.

Market Report -- In Play (THRX)  -  Apr 2, 2007
MSN MoneyTheravance announces positive results of clinical program in beyond Advair collaboration Co announces the results of two studies in an ongoing Phase 2b

Theravance to Participate in Investor Conferences in May 2007  -  Apr 24, 2007
Market Wire (press release)...focusing on treating serious Gram-positive bacterial infections with Astellas Pharma Inc. and the Beyond Advair collaboration with GlaxoSmithKline.

Theravance (THRX) Higher After Compound Shows Clinical Significance  -  Apr 2, 2007
StreetInsider.com (subscription),GSK642444 ('444) and GSK159797 ('797), the lead long-acting Beta2 agonist compounds in the Beyond Advair collaboration with GlaxoSmithKline (NYSE: GSK).

London shares weak, off lows midafternoon  -  Apr 24, 2007
Hemscott,The broker said the company's vaccines and respiratory products account for 25 pct of 2012 estimated sales, and with its two franchises -- Advair and

London shares remain lower midday, Dow seen weaker, Yell slumps on ...  -  Apr 24, 2007
ABCmoney.co.uk,The broker said the company's vaccines and respiratory products account for 25 pct of 2012 estimated sales, and with its two franchises -- Advair and

WeissComm Partners Announces Several New Hires to Strengthen and ...  -  Apr 23, 2007
PR Newswire (press release),...and several products for GlaxoSmithKline, including Advair(R), for the treatment of asthma and chronic obstructive pulmonary disease, Engerix-B(R),

WeissComm Partners Announces Several New Hires to Strengthen and ...  -  Apr 23, 2007
PR Newswire (press release),...and several products for GlaxoSmithKline, including Advair(R), for the treatment of asthma and chronic obstructive pulmonary disease, Engerix-B(R),

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional